• Biophytis will hold a second ordinary and extraordinary shareholders' meeting on November 27, 2026, in Ivry-sur-Seine.
• The unchanged agenda includes approval of the 2025 financial statements.
• The November 12 meeting lacked a quorum, with participation representing 12.46% of capital versus thresholds of 20% for ordinary business, 25% for extraordinary business.
• Ordinary business requires no quorum at the reconvened meeting; extraordinary business requires 20% of voting shares.
• The company is considering seeking an ad hoc representative for absent shareholders to help secure the required quorum.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biophytis SA published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.